CSI FOCUS D-HF: The future of device-based therapies and diagnostics for heart failure: The CMO view
Friday, 23 April 2021 16:00 CEST
Moderator:
Howard Levin, Coridea, New York, USA
Q&A moderator:
Zoar Engelman, Coridea, New York, USA
Panelists:
Philip Adamson, CMO, Abbott HF
William Abraham, CMO, V-Wave
Kenneth Stein, CMO, Boston Scientific CRM
Robin Germany, CMO, Respicardia
Todd Brinton, CMO, Edwards
PROGRAM
Live panel discussion providing the attendees with a current view of the scientific and clinical needs of these companies for new or updated diagnostics and therapies. The attendees will also be able to answer questions of the panelists.
This session is supported by:
